Mizuho Maintains Buy on HCA Healthcare, Raises Price Target to $325
Portfolio Pulse from Benzinga Newsdesk
Mizuho analyst Ann Hynes has maintained a 'Buy' rating on HCA Healthcare (NYSE:HCA) and raised the price target from $305 to $325.
July 11, 2023 | 11:22 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Mizuho has maintained a 'Buy' rating on HCA Healthcare and raised the price target from $305 to $325.
The raised price target by Mizuho indicates a positive outlook for HCA Healthcare. This could potentially attract more investors, driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100